These include: These medicines may be affected by hydroxocobalamin, or may affect how well it works
10-unit minimum order quantity
Clear solution with extended shelf-life
Phase 3 data confirms Retatrutide outperforms Wegovy by nearly 2x for weight loss
Disclosure of interest: Jenna Broman: nothing to disclose, Daniela Pinter: nothing to disclose, Simon Fandler-Hfler: nothing to disclose, Bettina von Sarnowski: nothing to disclose, Mohamed Elmegiri: nothing to disclose, Thomas Gattringer: nothing to disclose, Robert Malinowski: nothing to disclose, Juha Martola: nothing to disclose, Stefan Ropele: nothing to disclose, Ulf Schminke: nothing to disclose, Turgut Tatlisumak: nothing to disclose, Christian Enzinger: nothing to disclose, Karoliina Aarnio: nothing to disclose, Jukka Putaala: nothing to disclose E-Posters - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE P2226 - ESOC25-903 LONG-TERM SOCIAL COGNITIVE IMPAIRMENT AFTER ISCHEMIC STROKE: PREVALENCE AND IMPACT OF LESION VOLUME AND LOCATION Gisle Berg Helland 1,2,3 , Brian Anthony Enriquez 4 , Mona Beyer 2 , Henning Stople Rise 1,2 , Hkon Ihle-Hansen 3 , Stein Andersson 5,6 , Ramune Grambaite 7,8 , Helle Stangeland 9,10 , Anja Vaskinn 11,12 , Hege Ihle-Hansen 3,4 , Harbo Hanne Flinstad 2,4 , Einar A Hogestol 4,5,13 , Guri Hagberg 4 , Anne Hege Aamodt 4,14 1 Department of Neurology, Oslo University Hospital, Oslo, Norway, Department of Medical Research, Brum Hospital, Vestre Viken Hospital Trust, Drammen, Norway, Institute of Clinical Medicine, University of Oslo, Oslo, Norway, Oslo, Norway, 2 Institute of Clinical Medicine, University of Oslo, Oslo, Norway, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Norway, Oslo, Norway, 3 Department of Medical Research, Brum Hospital, Vestre Viken Hospital Trust, Drammen, Norway, Oslo, Norway, 4 Department of Neurology, Oslo University Hospital, Oslo, Norway, Oslo, Norway, 5 Department of Psychology, University of Oslo, Oslo, Norway, Oslo, Norway, 6 Psychosomatic Medicine and CL Psychiatry, Oslo University Hospital, Oslo, Norway, Oslo, Norway, 7 Department of Psychology, Norwegian Institute of Science and Technology, Trondheim, Norway, Trondheim, Norway, 8 Health Services Research Unit (HKH), Akershus University Hospital, Lrenskog, Norway, Oslo, Norway, 9 Department of Research and Innovation, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway, Oslo, Norway, 10 SHARE Centre for Resilience in Healthcare, Department of Quality and Health Technology, University of Stavanger, Norway, Stavanger, Norway, 11 Centre for Precision Psychiatry, Institute of Clinical Medicine, University of Oslo, Oslo, Norway, 12 Centre for Research and Education in Forensic Psychiatry, Oslo University Hospital, Oslo, Norway, Oslo, Norway, 13 Institute of Clinical Medicine, University of Oslo, Oslo, Norway, Oslo, Norway, 14 Department of neuromedicine and movement science, The Norwegian University of Science and Technology, Trondheim, Norway, Oslo, Norway Background and Aims: Social cognition, with emotion recognition as a key component, is recognized as a core cognitive domain, yet research on post stroke outcomes remains limited
